PhotoBioCure™ applies to most common surgical operations in the world and we talk about several billion dollars market.
Being in Poland PolTiss has access to the best research staff, the finest lab space and very attractive granting programmes.
Investing in PolTiss gives very clear exit opportunity for investors.
PhotoBioCure™ technology is already patented in US and Poland (European procedure is in progress) and PolTiss holds very attractive licenses for that.
However our main advantage is our team with unique composition of research&development experience with business competences.